View our informative webinar:
Cancer Testing and Treatment –New Questions, New Answers
Presented By: Dr. Skip Freedman, Dr. Edgar Clark and Dr. Jonathan Eneman
Each day utilization review and claims professionals working for health insurance payers face questions about what is covered and what is not in the field of oncology. The immense amount of research and study turns up new treatments every week. It is tough to keep up with new standards of care. How do such studies become part of the accepted standard of care in areas like breast cancer, multiple myeloma and other cancers? What must UR and claims professionals look for regarding emerging treatments that evolve into a standard of care?
Join Dr. Skip Freedman, along with Oncologist Dr Jonathan Eneman, and Radiologist Dr. Ed Clark for a 60-minute webinar that will provide insight into cutting-edge oncology treatments and how to differentiate experimental or investigational treatment from an accepted standard of care. Learn about new and emerging oncology practices for breast cancer, tandem transplants for myeloma, and new uses for PET scans — information that you can use to make better medical necessity decisions so your organization can deliver the best care to its enrollees.
Learn the latest about:
- What is investigational and what is experimental in oncology
- How these treatments become part of the accepted standard of care
- When accepted standards of care may be excluded from plan coverage
- The value of leading edge tests for breast cancer, including Oncotype DX, MRIs, BRCA testing
- When to consider covering tandem transplants for multiple myeloma
- How should PET scans be staged and with what frequency
- When and how an external review service fits into your oncology case management process
Webinar Agenda:
- An overview of today’s leading edge cancer treatments for breast cancer and multiple myeloma
- New facts about tandem transplants
- When to cover PET scans and when not
- Question and answer session
Who should attend?
Utilization review and claims professionals, medical directors, medical policy managers and care management professionals working with health insurance payers, including carriers, medical management firms, third party administrators and self insured organizations will find that this seminar clarifies the ever shifting border between what’s cutting-edge and what’s experimental or investigational.
Featured Speakers
*Dr. Skip Freedman, Executive Medical Director, frequently writes about medical necessity issues. He has years of experience successfully facilitating evidence based medical services for health plan providers nationwide.
*Dr. Ed Clark, has practiced radiology since 1975. He is a consultant at OHSU on medical policy issues in radiology. He is interested in strategies to reduce the number of inappropriate imaging tests.
*Dr. Jonathan Eneman, Attending in Hematology/Medical Oncology, Cancer Committee Chairman, Senior Investigator for Clinical Oncology Research
FREE OFFER: A special issue of “The Cutting Edge” covering the medical necessity of oncology treatments will be emailed to all attendees.